2004D-0188 - Draft Guidance for Industry on Premarketing Risk Assessment; Development and Use of Risk Minimization Action Plans; and Good Pharmacovigilance Practices and Pharmacoepidemiologic Assessment; Availability
FDA Comment Number : EC3
Submitter : Mr. John Coster Date & Time: 07/28/2004 11:07:36
Organization : National Association of Chain Drug Stores
Category : Association
Issue Areas/Comments
Please find the attachment comments from the National Association of Chain Drug Stores.